Publications

Find at Harvard

June 2024
Supplement

Legacy Partners (B)

By: Richard S. Ruback and Royce Yudkoff

Pre-abstract: Instructors should consider the timing of making videos available to students, as they may reveal key case details. Abstract: Stephen Holbrook and Austin Pulsipher (both HBS '19) had been leading Nutrishare since acquiring the company six months... View Details

23 Jan 2019
News

The Promise of Personalized Medicine

Subscribe on iTunes Subscribe on SoundCloud More Skydeck episodes As a little kid, Rich Horgan (MBA 2018) doesn’t remember thinking much about the differences between himself and his younger brother, Terry. But as he started to get older, he started to ask questions:... View Details

February 2006 (Revised February 2009)
Case

AIDS in Brazil

By: Rohit Deshpande and Ricardo Reisen de Pinho

Abbott Labs has reached an impasse with the Brazilian government in negotiations over the pricing of a new anti-AIDS drug, Kaletra. The Brazilian government threatens compulsory licensing unless Abbott drastically reduces the price of Kaletra. View Details

Keywords: Price; Government and Politics; Health Care and Treatment; Health Disorders; Rights; Negotiation; Business and Government Relations; Pharmaceutical Industry; Brazil

04 Sep 2014
News

Our focus was to get drug companies to invest money in ALS

He can no longer walk, talk, or swallow, but Avi Kremer (MBA 2007) won’t let that slow down his pursuit of a cure for ALS, a progressive neurodegenerative disease. As founder of Prize4Life, the nonprofit he launched in 2006 with HBS classmates and professors, Kremer... View Details

01 Mar 2017
News

How Deep Brain Stimulation Could Change Medicine

tremors in his bow whenever he practiced, he immediately knew that something in his body was out of sync. He was diagnosed with essential tremor, a neurological disorder that causes involuntary and rhythmic shaking of the arms or hands.... View Details

Keywords: Janelle Nanos

23 Mar 2016
News

Curing Parkinson’s Disease

HBS alumni Jonathan Solomon and Hampus Hillerstrom (both MBA 2007) play an important role in Jon Palfreman’s recent book Brain Storms: The Race to Unlock the Mysteries of Parkinson’s Disease. As the cofounders of NeuroPhage Pharmaceuticals, the pair is working to... View Details

21 Mar 2012
News

O'Donnells donate $30 million to Harvard

Keywords: Food Manufacturing; Manufacturing

January 2020
Case

Celata Bioinnovations

By: John R. Wells and Benjamin Weinstock

In December 2019, Jon Hu (HBS ‘19) and Dr. Samantha Dale Strasser, co-founders of Celata Bioinnovations, were raising $1 million to launch their company. They had founded Celata less than six months earlier with the aim of redefining the drug discovery process.... View Details

31 Jan 2013
News

Ex-Pimco CEO is an engine for charity

Keywords: Religious, Grantmaking, Civic, Professional, and Similar Organizations; Personal Services

October 2020 (Revised November 2023)
Case

COVID-19 Testing at Everlywell

By: Jeffrey J. Bussgang and Olivia Hull

In March 2020, as COVID-19 spreads rapidly across the U.S., Everlywell founder Julia Cheek considers how to respond as a small start-up specializing in at-home lab testing. After making dramatic budget cuts, she decides to pivot the organization to address the... View Details

May 2016 (Revised March 2020)
Teaching Note

Cyberdyne: A Leap to the Future

By: Doug J. Chung and Mayuka Yamazaki

Cyberdyne Inc. was a Japanese technology venture founded in 2004 by scientist Yoshiyuki Sankai to commercialize a hybrid assistive limb (HAL). HAL was a robotic exoskeleton system for people who had difficulty walking due to nervous system disabilities resulting from... View Details

Keywords: Health Disorders; Technological Innovation; Marketing Strategy; Decisions; Product Launch; Medical Devices and Supplies Industry

August 2008 (Revised September 2008)
Case

The Flaxil Label (A)

This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details

Keywords: Governing Rules, Regulations, and Reforms; Health Disorders; Product Launch; Negotiation Process; Business and Government Relations; Safety; Pharmaceutical Industry

Article

Putting Patients First: Social Marketing Strategies for Treating HIV in Developing Nations

By: Zoe Chance and Rohit Deshpandé

It is more than mere coincidence that the highest rates of HIV occur in the world's poorest countries. Of the over 40 million people currently living with HIV, 95 percent are in the developing world. The first part of this paper explores the economics of HIV and... View Details

Keywords: Health Disorders; Developing Countries and Economies; Poverty; Health Care and Treatment; Social Marketing; Perspective; Customer Focus and Relationships; Profit; Africa; Asia; South America

Find at Harvard

Read Now

11 Jul 2013
News

Making Lives Better

Autism Science Foundation, which she founded in 2009, was a result of Tepper Singer's passion to fuel scientific research. To that end, ASF, which is based in New York City, funds pre- and post-doctorate fellowships for young scientists who can use the data to apply... View Details

Keywords: Jill Radsken; autism; Social Assistance; Health, Social Assistance; Religious, Grantmaking, Civic, Professional, and Similar Organizations; Personal Services

January 2024 (Revised April 2024)
Case

Target Malaria: Editing Mosquitoes through Gene Drives

By: Shikhar Ghosh and Shweta Bagai

Target Malaria, a non-profit research consortium, is exploring the application of CRISPR-Cas9 gene editing technology to combat malaria in Sub-Saharan Africa. Its approach uses gene drives, a revolutionary tool, to suppress the population of malaria-carrying... View Details

Keywords: Health Disorders; Technological Innovation; Nonprofit Organizations; Business Strategy; Genetics; Ethics; Governing Rules, Regulations, and Reforms; United States; United Kingdom; Burkina Faso; Africa

June 2024
Supplement

Legacy Partners (A)

By: Richard S. Ruback and Royce Yudkoff

Instructors should consider the timing of making videos available to students, as they may reveal key case details.

Stephen Holbrook and Austin Pulsipher (both HBS '19) had been leading Nutrishare since acquiring the company six months earlier in mid-2021.... View Details